Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia

Thomas Röth, Roberta Rogowski, Steven Hull, +5

SLEEP

Tolerance to Daytime Sedative Effects of H1 Antihistamines

Gary S. Richardson, Timothy Roehrs, León Rosenthal, +2

Journal of Clinical Psychopharmacology

Sedative effects of antihistamines

Thomas Roth, Timothy Roehrs, Gail Koshorek, +2

Journal of Allergy and Clinical Immunology

Antiparasitic AgentMedicineForensic ToxicologyPharmacologyToxicology +5

Characteristics of Individuals Who Do or Do Not Seek Treatment for Chronic Insomnia

Edward J. Stepanski, Gail Koshorek, Frank Zorick, +3

Psychosomatics

Sleep DisordersSleepSleep DisorderPsychiatryIndividuals Who +9

The Dose Effects of Zolpidem on the Sleep of Healthy Normals

Lori Merlotti, Timothy Roehrs, Gail Koshorek, +3

Journal of Clinical Psychopharmacology

Sleep DisordersNormal Sleep PatternsDose EffectsPharmacotherapySleep-related Breathing Disorder +15

Relation between ambulatory actigraphy and laboratory polysomnography in insomnia practice and research

Dana Withrow, Thomas Roth, Gail Koshorek, +1

Journal of Sleep Research

Patterns of Sleepiness in Various Disorders of Excessive Daytime Somnolence

Frank Zorick, Timothy Roehrs, Gail Koshorek, +4

SLEEP

Sleep DisordersSleepSleep MedicineSleep DisorderAllergy +7

Dose-Related Effects of Estazolam on Sleep of Patients with Insomnia

Timothy Roehrs, Frank Zorick, Nancy Lord, +2

Journal of Clinical Psychopharmacology

Sleep and pain in humans with fibromyalgia and comorbid insomnia: double-blind, crossover study of suvorexant 20 mg versus placebo

Timothy Roehrs, Dana Withrow, Gail Koshorek, +3

Journal of Clinical Sleep Medicine

Effects of estazolam and triazolam on transient insomnia associated with phase‐shifted sleep

Paula K. Schweitzer, Gail Koshorek, Mark J. Muehlbach, +4

Human Psychopharmacology Clinical and Experimental

Sleep DisordersSleep HealthPsychotropic MedicationPhase‐shifted SleepParallel Group +19